Australian (ASX) Stock Market Forum

galumay

learner
Joined
17 September 2011
Posts
2,831
Reactions
1,458
More bad news for H1 2022, JAN continues to grow expenses faster than revenue - so not scaling up at all. Cash flow is negative now as well.

Only a small position in the personal portfolio, so i will sit on it a bit longer, but its looking like it cant scale at this point. I am making some allowances for the impact of covid, but its disappointing to see the failure to execute in a business I thought had significant potential.
 

galumay

learner
Joined
17 September 2011
Posts
2,831
Reactions
1,458
As per my post above, JAN seems unable to scale. I think KME is a much better business in the sector, my much larger position there probably a reflection of my relative conviction!
 
Joined
12 January 2008
Posts
5,837
Reactions
13,892
After losing 70%, price seems to have stopped falling. Worth placing in a reversal watch list.

JAN0508.PNG


I'd need to see a HVBB that pushes through 0.50 before I'd consider buying.
 

galumay

learner
Joined
17 September 2011
Posts
2,831
Reactions
1,458
Peter2, they had a horrible H1 and the market punished them accordingly, their recent update for the full year was more positive and I think that has probably put a floor under the price. The release of the FY results shortly will be interesting, will need to meet or exceed the earlier trading update or I suspect it will get punished again. Personally its the end of H1 this year that I will be watching for any evidence that they can actually scale the business and pivot to profitability.

(I realise you are looking at it from a trader's TA perspective, but thought you may appreciate an insight from my perspective on a more FA basis!)
 
Joined
12 January 2008
Posts
5,837
Reactions
13,892
@galumay I post on threads that you've responded hoping that you'll provide your current thoughts.
Your concerns on JAN were proven correct. I thought their recent update was positive also and that's why I put JAN into my reversal watch list.
Seems we're both waiting for more positive data. I need to see signs of demand (buyers) in the price chart. You need to see improved fundamentals.
 

galumay

learner
Joined
17 September 2011
Posts
2,831
Reactions
1,458
My suspicions with $JAN confirmed with the release of their AR for FY22, not that there was really any new info, just confirmation of the deteriorating margins meaning its just not scaling. Revenue growing, but FCF falling heavily, at least they have no debt and I will wait and see what they can achieve in normalised conditions without all the usual suspects to blame. Its only a very small position anyway due to my lack of conviction.

I just looked at the investor presentation - another red flag there, $JAN reference a "broker consensus table"
1f6a9.png


Screen Shot 2022-08-22 at 4.41.45 pm.png
 
Top